v3.22.2.2
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Sales, net of returns and allowances $ 1,548,798 $ (576,602) $ 1,575,652 $ 1,147,334
Cost of sales 9,515,547 11,549,187 16,459,102 32,570,616
Gross loss (7,966,749) (12,125,789) (14,883,450) (31,423,282)
Operating expenses        
Selling, general and administrative 34,753,017 10,579,586 59,693,419 24,470,953
Research and development 6,126,951 2,801,394 15,165,946 8,788,969
Total operating expenses 40,879,968 13,380,980 74,859,365 33,259,922
Loss from operations (48,846,717) (25,506,769) (89,742,815) (64,683,204)
Interest income (expense), net 27,716 18,599,130 (2,290,993) 23,040,886
Other income (loss) 13,413,500 (77,127,266) 13,413,500 (225,432,884)
Loss before benefit for income taxes (35,405,501) (84,034,905) (78,620,308) (267,075,202)
Benefit for income taxes 0 2,919,491 0 21,833,930
Net loss $ (35,405,501) $ (81,115,414) $ (78,620,308) $ (245,241,272)
Net loss per share of common stock        
Basic (in usd per share) $ (0.22) $ (0.66) $ (0.50) $ (1.99)
Diluted (in usd per share) $ (0.22) $ (0.63) $ (0.50) $ (1.90)
Weighted average shares used in computing net loss per share of common stock        
Basic (in shares) 160,213,944 123,584,023 157,117,380 123,186,350
Diluted (in shares) 160,213,944 129,251,351 157,117,380 128,853,678

Source